CCMB, Apollo Hospitals Announce Collaboration For Dry Swab Covid-19 Test

The Direct Amplification rapid RT-PCR (DArRT-PCR) test allows for rapid, safer and more cost-effective testing

Topics

Coronavirus Tests | Coronavirus | Apollo Hospitals

T E Narasimhan  |  Chennai 

Apollo Hospitals has been investing big in infrastructure and bringing in advanced technologies such as Proton Therapy for cancer treatment, which has resulted in a higher debt

The biological sample can be directly isolated from patients' swabs and it uses a one-step protocol

The CSIR-Centre for Cellular & Molecular Biology (CCMB) and Enterprise on Thursday announced a collaboration for joint manufacturing and commercialisation of a test to detect Covid-19.

The Direct Amplification rapid RT-PCR (DArRT-PCR) test allows for rapid, safer and more cost-effective testing. The biological sample can be directly isolated from patients' swabs and it uses a one-step protocol. “The virus will be here for some time, it seems, and those who test more frequently will be able to contain the impact of Covid-19 better. Cheaper, rapid and easy to use tests as these are the need of the hour. With Apollo and its vast network of hospitals and health services, we are positive about impacting many lives towards better health,” said Dr Rakesh Mishra, Director of CSIR-CCMB.

Sangita Reddy, Joint Managing Director, Group added the Group has always been at the forefront of cutting-edge medical technology and a pioneer in implementing the latest advances for the benefit of patients. Co-creating and commercialising an Indian solution in line with Atmanirbhar Bharat is an important landmark for Apollo Hospitals.

Dear Reader,

Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.

We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Thu, December 10 2020. 17:55 IST

RECENT NEWS

Revoluts Australian Banking Licence Game Changer

Revolut has spent much of its life insisting that it is more than a bank. In Australia, it has now decided that becoming... Read more

The AI Bank Is Coming, But Who Controls The Risk?

Artificial intelligence is no longer something banks discuss as a distant possibility. It is already working behind the ... Read more

ClearBank UK Profit Leads To European Growth

ClearBank has spent much of the past decade building the technology and regulatory infrastructure needed to challenge so... Read more

Bank Of London Continues To Rebuild

ClearBank’s progress shows that modern clearing and banking infrastructure can become a sizeable and profitable busine... Read more

JPMorgan's Berlin Moment: Chase Takes On Europe

There is something quietly symbolic about JPMorgan Chase choosing Berlin as its gateway into continental Europe. In a fo... Read more

What Strategy's Bitcoin Sale Really Tells Us

There is a moment in every bull run when the narrative starts to fray. Not with a crash, not with a scandal, but with so... Read more